| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_84d9adaa7e7ce01ce8020f5c721aba10 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6854 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
| filingDate |
1992-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_146d17dc822ccbfa48023865129b74d3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d26ffc5c6ba5ab420f2d89c583413b5c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3c10285c76031edc55d8bc33caa30857 |
| publicationDate |
1993-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-9310458-A1 |
| titleOfInvention |
Binding of milk allergens to a solid phase |
| abstract |
A method and composition useful for the detection of anti-milk-protein IgE antibodies patient in body fluids. A composition of milk protein extract, casein and β-lactoglobulin is useful for the detection of anti-milk-protein IgE antibodies. The furher addition of bovine gamma globulin to the composition improves the detection of such IgE antibodies. The method involves applying to a solid phase an amount of the composition in solution and drying. The solid phase is placed in contact with a patient test sample and the presence or amount of anti-milk-protein IgE antibodies is determined. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102331497-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104931710-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2282206-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103616520-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103616520-A |
| priorityDate |
1991-11-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |